ARTIVION INC (AORT)
Sector: Health Care
Sector: Health Care
ARTIVION INC - Executive Compensation
Senior Vice President, Clinical Research and Chief Medical Officer
Executive Compensation
Marshall S. Stanton, MD, serves as the Senior Vice President of Clinical Research and Chief Medical Officer at Artivion Inc., a leading medical device company focused on developing and commercializing innovative solutions for aortic and cardiovascular diseases. Dr. Stanton brings a wealth of experience to his role, with an extensive background in clinical research, cardiovascular medicine, and medical device development. He joined Artivion in 2021, and since then, he has been instrumental in driving the company's clinical research strategy and overseeing the development of new therapies and technologies. Prior to joining Artivion, Dr. Stanton held several leadership positions in the medical field. He spent over two decades at the Mayo Clinic, where he served as a Professor of Medicine and Consultant in the Division of Cardiovascular Diseases. During his tenure at Mayo Clinic, Dr. Stanton was actively involved in clinical research, leading numerous studies on cardiac arrhythmias, device therapy, and heart failure management. His research has been widely published in peer-reviewed journals, and he has received several awards for his contributions to the field of cardiovascular medicine. Dr. Stanton's expertise in clinical research and his deep understanding of the medical device industry make him a valuable asset to Artivion. As Senior Vice President of Clinical Research and Chief Medical Officer at Artivion, Dr. Stanton plays a crucial role in advancing the company's mission to improve patient outcomes through innovative medical solutions. He leads a team of researchers and clinicians in designing and executing clinical trials to evaluate the safety and efficacy of Artivion's products. Dr. Stanton also collaborates closely with the company's product development and regulatory teams to ensure that Artivion's devices meet the highest standards of quality and performance. Under his leadership, Artivion has made significant progress in developing novel therapies for aortic and cardiovascular diseases, positioning the company as a leader in the medical device industry.